Human platelet lysate‐derived extracellular vesicles enhance angiogenesis through <scp>miR</scp> ‐126

Abstract

PL is a biological source of available EVs with angiogenic effects involving a miRNAs-based cargo. These properties can be exploited for targeted molecular/biological manipulation of PL, by potentially developing a product exclusively manufactured of EVs.